A 3-Case Series of Autoimmune Haemolytic Anaemia and COVID-19: Is Plasma Exchange an Alternative?

Abstract COVID-19 has rarely been associated with immune-mediated phenomena such as autoimmune haemolytic anaemia (AIHA). Both cold hemolysis with cold agglutinin detection and warm haemolysis have been described with variable prognoses. Current treatment regimens are based on experience with other case series and case reports, which still represent a clinical challenge. Corticosteroids, red cell transfusions and rituximab have been successfully employed. We present 3 cases of AIHA in the context of COVID-19 disease, the first case successfully treated with plasma exchange and long-term follow-up of the 3 cases showing complete remission of anaemia..

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:3

Enthalten in:

SN comprehensive clinical medicine - 3(2021), 6 vom: 14. Apr., Seite 1420-1423

Sprache:

Englisch

Beteiligte Personen:

Ramos-Ruperto, L. [VerfasserIn]
García-Pérez, Eduardo [VerfasserIn]
Hernández-Maraver, D. [VerfasserIn]
Kerguelén-Fuentes, A. [VerfasserIn]
Viejo-Llorente, A. [VerfasserIn]
Robles-Marhuenda, Á. [VerfasserIn]
Busca-Arenzana, C. [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

Autoimmune haemolytic anaemia
COVID-19
Corticosteroids
Plasma exchange

Anmerkungen:

© The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021

doi:

10.1007/s42399-021-00884-6

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

SPR044224818